Literature DB >> 17848062

Overviews of pathogen emergence: which pathogens emerge, when and why?

S Cleaveland1, D T Haydon, L Taylor.   

Abstract

An emerging pathogen has been defined as the causative agent of an infectious disease whose incidence is increasing following its appearance in a new host population or whose incidence is increasing in an existing population as a result of long-term changes in its underlying epidemiology (Woolhouse and Dye 2001). Although we appear to be in a period where novel diseases are appearing and old diseases are spreading at an unprecedented rate, disease emergence per se is not a new phenomenon. It is almost certain that disease emergence is a routine event in the evolutionary ecology of pathogens, and part of a ubiquitous response of pathogen populations to shifting arrays of host species. While our knowledge of emerging diseases is, for the most part, limited to the time span of the human lineage, this history provides us with a modern reflection of these deeper evolutionary processes, and it is clear from this record that at many times throughout human history, demographic and behavioural changes in society have provided opportunities for pathogens to emerge.

Entities:  

Mesh:

Year:  2007        PMID: 17848062      PMCID: PMC7122528          DOI: 10.1007/978-3-540-70962-6_5

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  95 in total

1.  Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity).

Authors:  Paul D Thompson; David Buchner; Ileana L Pina; Gary J Balady; Mark A Williams; Bess H Marcus; Kathy Berra; Steven N Blair; Fernando Costa; Barry Franklin; Gerald F Fletcher; Neil F Gordon; Russell R Pate; Beatriz L Rodriguez; Antronette K Yancey; Nanette K Wenger
Journal:  Circulation       Date:  2003-06-24       Impact factor: 29.690

2.  Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients.

Authors:  Wei-Shiung Yang; Chi-Yuan Jeng; Ta-Jen Wu; Sachiyo Tanaka; Tohru Funahashi; Yuji Matsuzawa; Jao-Ping Wang; Chi-Ling Chen; Tong-Yuan Tai; Lee-Ming Chuang
Journal:  Diabetes Care       Date:  2002-02       Impact factor: 19.112

3.  Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study.

Authors:  C D Sjöström; L Lissner; H Wedel; L Sjöström
Journal:  Obes Res       Date:  1999-09

4.  Ramipril and the development of diabetes.

Authors:  S Yusuf; H Gerstein; B Hoogwerf; J Pogue; J Bosch; B H Wolffenbuttel; B Zinman
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

5.  Effect of ramipril on the incidence of diabetes.

Authors:  Jackie Bosch; Salim Yusuf; Hertzel C Gerstein; Janice Pogue; Patrick Sheridan; Gilles Dagenais; Rafael Diaz; Alvaro Avezum; Fernando Lanas; Jeffrey Probstfield; George Fodor; Rury R Holman
Journal:  N Engl J Med       Date:  2006-09-15       Impact factor: 91.245

6.  A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia.

Authors:  Ronald B Goldberg; David M Kendall; Mark A Deeg; John B Buse; Anthony J Zagar; Jane A Pinaire; Meng H Tan; Mehmood A Khan; Alfonso T Perez; Scott J Jacober
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

7.  A reduced-glycemic load diet in the treatment of adolescent obesity.

Authors:  Cara B Ebbeling; Michael M Leidig; Kelly B Sinclair; Jan P Hangen; David S Ludwig
Journal:  Arch Pediatr Adolesc Med       Date:  2003-08

8.  Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein.

Authors:  David J A Jenkins; Cyril W C Kendall; Augustine Marchie; Dorothea A Faulkner; Julia M W Wong; Russell de Souza; Azadeh Emam; Tina L Parker; Edward Vidgen; Karen G Lapsley; Elke A Trautwein; Robert G Josse; Lawrence A Leiter; Philip W Connelly
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

9.  Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.

Authors:  Alka M Kanaya; David Herrington; Eric Vittinghoff; Feng Lin; Deborah Grady; Vera Bittner; Jane A Cauley; Elizabeth Barrett-Connor
Journal:  Ann Intern Med       Date:  2003-01-07       Impact factor: 25.391

10.  Increased CD36 protein as a response to defective insulin signaling in macrophages.

Authors:  Chien-Ping Liang; Seongah Han; Haruka Okamoto; Ronald Carnemolla; Ira Tabas; Domenico Accili; Alan R Tall
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

View more
  43 in total

1.  Combining mathematics and empirical data to predict emergence of RNA viruses that differ in reservoir use.

Authors:  C Brandon Ogbunugafor; Sanjay Basu; Nadya M Morales; Paul E Turner
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-06-27       Impact factor: 6.237

Review 2.  Zoonotic Potential of Simian Arteriviruses.

Authors:  Adam L Bailey; Michael Lauck; Samuel D Sibley; Thomas C Friedrich; Jens H Kuhn; Nelson B Freimer; Anna J Jasinska; Jane E Phillips-Conroy; Clifford J Jolly; Preston A Marx; Cristian Apetrei; Jeffrey Rogers; Tony L Goldberg; David H O'Connor
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

3.  Adaptation of tobacco etch potyvirus to a susceptible ecotype of Arabidopsis thaliana capacitates it for systemic infection of resistant ecotypes.

Authors:  Jasna Lalić; Patricia Agudelo-Romero; Purificación Carrasco; Santiago F Elena
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-06-27       Impact factor: 6.237

4.  Environmental Variables Associated with Hantavirus Reservoirs and Other Small Rodent Species in Two National Parks in the Paraná Delta, Argentina: Implications for Disease Prevention.

Authors:  María Victoria Vadell; Isabel Elisa Gómez Villafañe
Journal:  Ecohealth       Date:  2016-05-11       Impact factor: 3.184

Review 5.  Cytopathic bovine viral diarrhea viruses (BVDV): emerging pestiviruses doomed to extinction.

Authors:  Ernst Peterhans; Claudia Bachofen; Hanspeter Stalder; Matthias Schweizer
Journal:  Vet Res       Date:  2010-03-04       Impact factor: 3.683

6.  Identification of bacterial infection in neotropical primates.

Authors:  Andre Menezes-Costa; Erik Machado-Ferreira; Carolina M Voloch; Cibele R Bonvicino; Hector N Seuánez; Orilio Leoncini; Carlos A G Soares
Journal:  Microb Ecol       Date:  2013-08       Impact factor: 4.552

Review 7.  Pasteurella multocida: from zoonosis to cellular microbiology.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

8.  Environmental monitoring and analysis of faecal contamination in an urban setting in the city of Bari (Apulia region, Italy): health and hygiene implications.

Authors:  Elvira Tarsitano; Grazia Greco; Nicola Decaro; Francesco Nicassio; Maria Stella Lucente; Canio Buonavoglia; Maria Tempesta
Journal:  Int J Environ Res Public Health       Date:  2010-11-09       Impact factor: 3.390

9.  Search strategy has influenced the discovery rate of human viruses.

Authors:  Ronald Rosenberg; Michael A Johansson; Ann M Powers; Barry R Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-05       Impact factor: 11.205

10.  The avian XPR1 gammaretrovirus receptor is under positive selection and is disabled in bird species in contact with virus-infected wild mice.

Authors:  Carrie Martin; Alicia Buckler-White; Kurt Wollenberg; Christine A Kozak
Journal:  J Virol       Date:  2013-07-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.